Horizon Therapeutics Common
|
17.0 |
$1.0B |
|
9.3M |
107.76 |
Mirati Therapeutics Common
|
12.6 |
$745M |
|
5.1M |
146.69 |
United Therapeutics Corp Common
(UTHR)
|
11.1 |
$656M |
|
3.0M |
216.08 |
Apellis Pharmaceuticals Common
(APLS)
|
6.9 |
$405M |
|
8.6M |
47.28 |
Argenx Se Sponsored ADR
(ARGX)
|
5.7 |
$338M |
|
965k |
350.19 |
Sarepta Therapeutics Common
(SRPT)
|
5.2 |
$308M |
|
3.4M |
90.05 |
Ascendis Pharma Sponsored ADR
(ASND)
|
4.6 |
$269M |
|
2.0M |
134.53 |
Biomarin Pharmaceutical Common
(BMRN)
|
4.2 |
$247M |
|
2.8M |
88.35 |
Amicus Therapeutics Common
(FOLD)
|
3.6 |
$214M |
|
19M |
11.55 |
Alnylam Pharmaceuticals Common
(ALNY)
|
3.1 |
$182M |
|
1.1M |
169.58 |
Iovance Biotherapeutics Common
(IOVA)
|
2.8 |
$166M |
|
8.7M |
19.09 |
Xenon Pharmaceuticals Common
(XENE)
|
2.6 |
$156M |
|
5.0M |
31.24 |
Iveric Bio Common
|
2.1 |
$121M |
|
7.3M |
16.72 |
Madrigal Pharmaceuticals Common
(MDGL)
|
2.0 |
$121M |
|
1.4M |
84.74 |
Spdr Series Trust - S&p Biotech Etf
(XBI)
|
2.0 |
$118M |
|
1.1M |
111.96 |
Arena Pharmaceuticals Common
|
1.9 |
$115M |
|
1.2M |
92.94 |
Monte Rosa Therapeutics Common
(GLUE)
|
1.1 |
$68M |
|
3.3M |
20.42 |
Kura Oncology Common
(KURA)
|
0.9 |
$56M |
|
4.0M |
14.00 |
Acadia Pharmaceuticals Common
(ACAD)
|
0.9 |
$51M |
|
2.2M |
23.34 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.8 |
$48M |
|
2.2M |
21.89 |
Aadi Biosciences Common
(AADI)
|
0.7 |
$44M |
|
1.8M |
24.15 |
Mersana Therapeutics Common
(MRSN)
|
0.7 |
$42M |
|
6.8M |
6.22 |
Mannkind Corp Common
(MNKD)
|
0.7 |
$39M |
|
8.8M |
4.37 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.7 |
$38M |
|
3.2M |
11.88 |
Praxis Precision Medicines Common
|
0.6 |
$35M |
|
1.8M |
19.70 |
Design Therapeutics Common
(DSGN)
|
0.6 |
$35M |
|
1.6M |
21.41 |
Kymera Therapeutics Common
(KYMR)
|
0.6 |
$35M |
|
550k |
63.49 |
Cymabay Therapeutics Common
|
0.6 |
$35M |
|
10M |
3.38 |
Pmv Pharmaceuticals Common
(PMVP)
|
0.6 |
$34M |
|
1.5M |
23.10 |
Krystal Biotech Common
(KRYS)
|
0.6 |
$33M |
|
475k |
69.95 |
Avidity Biosciences Common
(RNA)
|
0.5 |
$29M |
|
1.2M |
23.77 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.3 |
$20M |
|
6.0M |
3.37 |
Nuvalent Common
(NUVL)
|
0.3 |
$18M |
|
1.1M |
16.71 |
Tango Therapeutics Common
(TNGX)
|
0.3 |
$17M |
|
1.6M |
10.94 |
Dice Therapeutics Common
|
0.2 |
$14M |
|
563k |
25.31 |
Avadel Pharmaceuticals Sponsored ADR
|
0.2 |
$14M |
|
1.7M |
8.08 |
Adverum Biotechnologies Common
|
0.2 |
$12M |
|
7.0M |
1.76 |
Io Biotech Common
(IOBT)
|
0.2 |
$10M |
|
2.1M |
4.98 |
Genocea Biosciences Common
(GNCAQ)
|
0.1 |
$5.9M |
|
5.1M |
1.16 |
Fennec Pharmaceuticals Common
(FENC)
|
0.1 |
$5.3M |
|
1.2M |
4.40 |